Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

Title
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 15, Issue 11, Pages 3872-3880
Publisher
American Association for Cancer Research (AACR)
Online
2009-05-27
DOI
10.1158/1078-0432.ccr-08-1946

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started